These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23751368)

  • 1. A case of globular glial tauopathy presenting clinically as alzheimer disease.
    SantaCruz KS; Rottunda SJ; Meints JP; Bearer EL; Bigio EH; McCarten JR
    Alzheimer Dis Assoc Disord; 2015; 29(1):82-4. PubMed ID: 23751368
    [No Abstract]   [Full Text] [Related]  

  • 2. Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia.
    Graff-Radford J; Josephs KA; Parisi JE; Dickson DW; Giannini C; Boeve BF
    JAMA Neurol; 2016 Jan; 73(1):123-5. PubMed ID: 26571405
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity.
    Liu AJ; Chang JE; Naasan G; Boxer AL; Miller BL; Spina S
    Neurocase; 2020 Apr; 26(2):91-97. PubMed ID: 32090696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
    Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease.
    Besser LM; Mock C; Teylan MA; Hassenstab J; Kukull WA; Crary JF
    J Neuropathol Exp Neurol; 2019 Mar; 78(3):219-228. PubMed ID: 30715383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.
    Jellinger KA; Alafuzoff I; Attems J; Beach TG; Cairns NJ; Crary JF; Dickson DW; Hof PR; Hyman BT; Jack CR; Jicha GA; Knopman DS; Kovacs GG; Mackenzie IR; Masliah E; Montine TJ; Nelson PT; Schmitt F; Schneider JA; Serrano-Pozo A; Thal DR; Toledo JB; Trojanowski JQ; Troncoso JC; Vonsattel JP; Wisniewski T
    Acta Neuropathol; 2015 May; 129(5):757-62. PubMed ID: 25778618
    [No Abstract]   [Full Text] [Related]  

  • 7. Globular glial tauopathy presenting as non-fluent/agrammatic variant primary progressive aphasia with chorea.
    Kim EJ; Lee MJ; Lee JH; Lee YM; Shin JH; Shin MJ; Choi KU; Jung NY; Pak K; Hwang C; Ahn JW; Sung S; Spina S; Grinberg LT; Seeley WW; Huh GY
    Parkinsonism Relat Disord; 2017 Nov; 44():159-161. PubMed ID: 28923295
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphological characterisation of glial and neuronal tau pathology in globular glial tauopathy (Types II and III).
    Tanaka H; Toyoshima Y; Kawakatsu S; Kobayashi R; Yokota O; Terada S; Kuroda S; Miura T; Higuchi Y; Otsu H; Sanpei K; Otani K; Ikeuchi T; Onodera O; Kakita A; Takahashi H
    Neuropathol Appl Neurobiol; 2020 Jun; 46(4):344-358. PubMed ID: 31600825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical globular glial tauopathy with a combination of types I and II pathology.
    Kon T; Mori F; Arai A; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Wakabayashi K
    Neuropathology; 2019 Apr; 39(2):127-134. PubMed ID: 30723950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.
    Ferrer I; López-González I; Carmona M; Arregui L; Dalfó E; Torrejón-Escribano B; Diehl R; Kovacs GG
    J Neuropathol Exp Neurol; 2014 Jan; 73(1):81-97. PubMed ID: 24335532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An Autopsy Case of Globular Glial Tauopathy Presenting with Amyotrophic Lateral Sclerosis with Dementia].
    Sasaki R; Mimuro M; Kokubo Y; Imai H; Yoshida M; Tomimoto H
    Brain Nerve; 2016 Aug; 68(8):945-50. PubMed ID: 27503823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globular glial tauopathy Type I presenting with behavioral variant frontotemporal dementia.
    Hirano M; Iritani S; Fujishiro H; Torii Y; Kawashima K; Sekiguchi H; Habuchi C; Yamada K; Ikeda T; Hasegawa M; Ikeuchi T; Yoshida M; Ozaki N
    Neuropathology; 2020 Oct; 40(5):515-525. PubMed ID: 33463808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Progression of White Matter Signal Changes and Frontotemporal Atrophy in Globular Glial Tauopathy.
    Ohno Y; Ikeda T; Sakurai K; Yamada K; Tomonari T; Iwasaki Y; Yoshida M; Matsukawa N
    J Neuropathol Exp Neurol; 2021 Apr; 80(5):480-483. PubMed ID: 33306785
    [No Abstract]   [Full Text] [Related]  

  • 14. Globular glial tauopathy Type II: Clinicopathological study of two autopsy cases.
    Tanaka H; Kawakatsu S; Toyoshima Y; Miura T; Mezaki N; Mano A; Sanpei K; Kobayashi R; Hayashi H; Otani K; Ikeuchi T; Onodera O; Kakita A; Takahashi H
    Neuropathology; 2019 Apr; 39(2):111-119. PubMed ID: 30646429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.
    Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA
    Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal sclerosis dementia with tauopathy.
    Beach TG; Sue L; Scott S; Layne K; Newell A; Walker D; Baker M; Sahara N; Yen SH; Hutton M; Caselli R; Adler C; Connor D; Sabbagh M
    Brain Pathol; 2003 Jul; 13(3):263-78. PubMed ID: 12946017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Globular glial tauopathies (GGT): consensus recommendations.
    Ahmed Z; Bigio EH; Budka H; Dickson DW; Ferrer I; Ghetti B; Giaccone G; Hatanpaa KJ; Holton JL; Josephs KA; Powers J; Spina S; Takahashi H; White CL; Revesz T; Kovacs GG
    Acta Neuropathol; 2013 Oct; 126(4):537-544. PubMed ID: 23995422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and regional vulnerability in frontotemporal tauopathies.
    Forrest SL; Kril JJ; Halliday GM
    Acta Neuropathol; 2019 Nov; 138(5):705-727. PubMed ID: 31203391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticobasal degeneration: selected developments.
    Lang AE
    Mov Disord; 2003 Sep; 18 Suppl 6():S51-6. PubMed ID: 14502656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.